Huo M - Search Results

1

Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.

Eriksson BI, Dahl OE, Feuring M, Clemens A, Noack H, Hantel S, Friedman RJ, Huo M. Eriksson BI, et al. Among authors: huo m. Thromb Res. 2012 Nov;130(5):818-20. doi: 10.1016/j.thromres.2012.07.004. Epub 2012 Jul 26. Thromb Res. 2012. PMID: 22840686

2

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials.

Eriksson BI, Dahl OE, Rosencher N, Clemens A, Hantel S, Feuring M, Kreuzer J, Huo M, Friedman RJ. Eriksson BI, et al. Among authors: huo m. Thromb J. 2015 Nov 17;13:36. doi: 10.1186/s12959-015-0067-8. eCollection 2015. Thromb J. 2015. PMID: 26578849 Free PMC article.

3

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.

Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ; RE-NOVATE II Study Group. Eriksson BI, et al. Among authors: huo mh. Thromb Haemost. 2011 Apr;105(4):721-9. doi: 10.1160/TH10-10-0679. Epub 2011 Jan 12. Thromb Haemost. 2011. PMID: 21225098 Clinical Trial.

4

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

RE-MOBILIZE Writing Committee; Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. RE-MOBILIZE Writing Committee, et al. Among authors: huo mh. J Arthroplasty. 2009 Jan;24(1):1-9. doi: 10.1016/j.arth.2008.01.132. Epub 2008 Apr 14. J Arthroplasty. 2009. PMID: 18534438 Clinical Trial.

5

New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: are they really better?

Huo MH. Huo MH. Thromb Haemost. 2011 Jul;106(1):45-57. doi: 10.1160/TH10-10-0653. Epub 2011 May 5. Thromb Haemost. 2011. PMID: 21544312 Review.

6

A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).

Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD; EXPERT Study Group. Turpie AG, et al. Among authors: huo mh. Thromb Haemost. 2009 Jan;101(1):68-76. Thromb Haemost. 2009. PMID: 19132191 Clinical Trial.

7

The efficacy and safety of rivaroxaban for venous thromboembolism prophylaxis after total hip and total knee arthroplasty.

Russell RD, Hotchkiss WR, Knight JR, Huo MH. Russell RD, et al. Thrombosis. 2013;2013:762310. doi: 10.1155/2013/762310. Epub 2013 Feb 21. Thrombosis. 2013. PMID: 23533746 Free PMC article.

8

Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.

Garza R, Huo MH. Garza R, et al. Expert Rev Cardiovasc Ther. 2012 Apr;10(4):423-7. doi: 10.1586/erc.12.15. Expert Rev Cardiovasc Ther. 2012. PMID: 22458575 Review.

9

The eighth American college of chest physicians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies.

Huo MH, Spyropoulos AC. Huo MH, et al. J Thromb Thrombolysis. 2011 Feb;31(2):196-208. doi: 10.1007/s11239-010-0500-6. J Thromb Thrombolysis. 2011. PMID: 20686823

10

New anticoagulants for thromboprophylaxis after total knee arthroplasty.

Brown TS, Huo MH. Brown TS, et al. Am J Orthop (Belle Mead NJ). 2013 Sep;42(9):424-9. Am J Orthop (Belle Mead NJ). 2013. PMID: 24078968 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

767 results

Search Page